LBF20107PG15: Difference between revisions
No edit summary |
No edit summary |
||
| (18 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
| Line 4: | Line 6: | ||
|LipidBank=XPR1776 | |LipidBank=XPR1776 | ||
|LipidMaps=LMFA03010106 | |LipidMaps=LMFA03010106 | ||
|SysName=9- | |SysName=9-Oxo- (11beta,15S) -dihydroxy-prost-trans-13-en-1-oic acid | ||
|Common Name=&& | |Common Name=&&11beta-Prostaglandin E_1&&9-Oxo- (11beta,15S) -dihydroxy-prost-13(E)-en-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=11 beta -PGE1 is reported to contract the rat uterus and guinea pig ileum with less potent activity.[[Reference:Ramwell_PW:Shaw_JE:Corey_EJ:Andersen_N:,Nature,1969,221,1251|{{RelationTable/GetFirstAuthor|Reference:Ramwell_PW:Shaw_JE:Corey_EJ:Andersen_N:,Nature,1969,221,1251}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | |||
Latest revision as of 08:11, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1776 |
| LipidMaps | LMFA03010106 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20107PG15 |
| 11β-Prostaglandin E1 | |
|---|---|
| |
| Structural Information | |
| 9-Oxo- (11β,15S) -dihydroxy-prost-trans-13-en-1-oic acid | |
| |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@H](CC1=O)O)CC |
| Physicochemical Information | |
| 11 beta -PGE1 is reported to contract the rat uterus and guinea pig ileum with less potent activity. Ramwell_PW et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
